APOE and tauopathy: We also postulate that tauopathy can be regulated by metabolic abnormalities such as lipid dysfunction controlled by apolipoprotein E (ApoE), which is an essential ligand for the uptake and clearance of atherogenic lipoproteins [90,103,104].